BBSRC Portfolio Analyser

Award details

Development of a flow-through array diagnostic device to demonstrate commercial potential of nanoparticle conjugation IP

ReferenceBB/C524362/1
Principal Investigator / Supervisor Dr Robert Wilson
Co-Investigators /
Co-Supervisors
Institution University of Liverpool
DepartmentChemistry
Funding typeResearch
Value (£) 59,454
StatusCompleted
TypeResearch Grant
Start date 19/09/2005
End date 18/09/2006
Duration12 months

Abstract

During the grant period of BBSRC 26/E16354 we have focused on academic aspects of our nanoparticle conjugation method. The aim was to show that we could conjugate a broad range of recognition molecules to different nanoparticles and use them in specific biomolecular assays. The platforms for these demonstrations were various microbead assays, but these do not readily transform into the kind of applications that appeal to companies and investors. To overcome this problem we propose to develop a simple analytical device that can be used to demonstrate the commercial potential of our method. At the end of the project we would have a prototype device that can be used to demonstrate potential value to prospective licensees. A license deal is more likely if a working device can be demonstrated rather than simply highlighting the potential of the technology. The proposal will also support the evaluation of the market potential and commercial feasibility of the proposed approach. Successful demonstration of this will provide proof-of-concept of the technology to expand market applicability of the core platform technology IP, allow development of future IP, and help secure license partners.

Summary

During the grant period of BBSRC 26/E16354 we have focused on academic aspects of our nanoparticle conjugation method. The aim was to show that we could conjugate a broad range of recognition molecules to different nanoparticles and use them in specific biomolecular assays. The platforms for these demonstrations were various microbead assays, but these do not readily transform into the kind of applications that appeal to companies and investors. To overcome this problem we propose to develop a simple analytical device that can be used to demonstrate the commercial potential of our method. At the end of the project we would have a prototype device that can be used to demonstrate potential value to prospective licensees. A license deal is more likely if a working device can be demonstrated rather than simply highlighting the potential of the technology. The proposal will also support the evaluation of the market potential and commercial feasibility of the proposed approach. Successful demonstration of this will provide proof-of-concept of the technology to expand market applicability of the core platform technology IP, allow development of further IP, and help secure license partners
Committee Closed Committee - Engineering & Biological Systems (EBS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file
back to list new search